Its a dead duck, page-68

He’s been at my place playing Monolopoly Cane.



——

but again H reminds us of a very intriguing point about Kazia - nearly all our trials are paid for by the various oncology groups themselves and each and every day they pour their resources and treasure into these studies to help sufferers, which is also qualifying Paxalisib in so many focuses.

the market is not offering any value into the current SP at all for all these works!

the market is slow and stupid which is why there’s always opportunities to find value - particularly in this area where you need a really deep dive in order to understand what’s at stake here… it takes effort. So many will come later rushing in with the herd.

the market will follow the undeniable success’ after data and approvals etc… but as we have seen forgets past success’ over time.

any way accumulation is the name of the game for me - I have my retirement bag but strangely there’s room for more!